Lenvima 4 mg Capsule 20’s

Lenvima 4 mg Capsule contains lenvatinib, a tyrosine kinase inhibitor used in the treatment of certain types of cancers such as thyroid cancer, liver cancer, and renal cell carcinoma. Lenvatinib works by blocking the action of proteins that promote cancer cell growth and angiogenesis (blood vessel formation), thereby slowing or stopping tumor growth.

Uses:

• Thyroid Cancer: For patients with progressive, radioactive iodine-refractory differentiated thyroid cancer.
• Advanced Renal Cell Carcinoma (RCC): Often used in combination with other medications for improved efficacy.
• Hepatocellular Carcinoma (HCC): First-line treatment option for certain patients with unresectable liver cancer.

How Lenvima 4 mg Capsule Works:

Lenvatinib targets multiple tyrosine kinases involved in tumor growth and angiogenesis. By inhibiting these pathways, it slows tumor progression, suppresses cancer cell proliferation, and reduces the formation of new blood vessels that supply tumors.

Common Side Effects:

• High blood pressure
• Diarrhea
• Fatigue
• Loss of appetite
• Weight loss

Serious Side Effects (Seek Immediate Medical Attention):

• Cardiovascular Issues: High blood pressure crises or heart problems.
• Severe Liver Toxicity: Elevated liver enzymes may indicate liver problems.
• Gastrointestinal Perforation: Symptoms include severe abdominal pain or changes in bowel habits.

Key Features:

• Contains lenvatinib, a potent multi-kinase inhibitor.
• Slows cancer progression by inhibiting key growth factors and angiogenesis pathways.
• Used in various types of cancer, including thyroid, renal, and liver cancers.
• Administered orally for targeted cancer treatment.

Precautions:

• Pregnancy and Breastfeeding: Lenvima is not recommended due to potential harm to the fetus.
• Regular Monitoring: Blood pressure, liver function, and other parameters need frequent assessment during treatment.
• Drug Interactions: Inform your doctor about any other medications or supplements being taken.

Frequently Asked Questions (FAQ):

1. What types of cancer does Lenvima treat?
   Lenvima is used for thyroid cancer, advanced renal cell carcinoma, and certain types of liver cancer.
2. How is Lenvima taken?
   It is taken orally, typically once daily, as directed by your healthcare provider.
3. Is Lenvima safe during pregnancy?
   No, it may cause harm to the fetus and is not recommended for use during pregnancy.
4. What should I monitor while using Lenvima?
   Blood pressure, liver function, and kidney function should be regularly monitored due to potential side effects.
5. Can Lenvima interact with other medications?
   Yes, it may interact with certain medications. Inform your healthcare provider of all drugs and supplements you are taking.

References:

1. Eisai Inc. – Lenvima (Lenvatinib) Product Information
   Available from: https://medlineplus.gov/druginfo/meds/a615015.html
   Accessed on: November 10, 2024.
2. European Medicines Agency (EMA) – Lenvatinib Information
   Available from: https://www.ncbi.nlm.nih.gov/books/NBK567768/
   Accessed on: November 10, 2024.